Asia is on course to become the next hot spot for global medical device companies, as the region witnesses economic growth, increased health care spending, and robust regulatory reforms. In this white paper, part of CSOFT's series on the global life science market and regulatory landscape, the Asian medical device market's landscape and regulatory overview will be discussed. In particular, the medical device markets and regulatory landscapes of seven major players in the region (China, Japan, Korea, Malaysia, Australia, Thailand and India) are closely examined, along with the critical role of Language Service Providers (LSPs) in Asia.